Interestingly, microRNA-137 (miR-137) is the only miRNA empirically shown to target LSD1 and is implicated in psychiatric illness including schizophrenia (Sun et al., 2011; Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014; Mahmoudi and Cairns, 2017). The gene discussed is KDM1A; the disease is schizophrenia.